Literature DB >> 35136735

Barophenotypic Characterization - The key to Person Centric Management of Obesity.

Sanjay Kalra1,2, Sambit Das3, Sunil Kota4, Beatrice Anne5, Ashok Kumar6, Hitesh Punyani7, Ameya Joshi8, Ambika Gopalakrishnan Unnikrishnan9, Saptarshi Bhattacharya10, Nitin Kapoor11,12.   

Abstract

Obesity is now recognized as a chronic disease by many international medical societies. However, its comprehensive assessment is still a challenge in most clinical settings. This paper describes a novel practical approach to assess the barophenotype of a given individual. The word barophenotype is a portmanteau of "baro," which means weight, and phenotype, which reflects an external expression of a trait. This can be easily assessed using an ABCDE framework, encompassing the Adipose topography, Barophenotypic Behavior, Comorbidity assessment, Dysfunctionality, and Expectations. Furthermore, the utility of this framework in determining an appropriate person-centric therapeutic plan has also been described. Copyright:
© 2021 Indian Journal of Endocrinology and Metabolism.

Entities:  

Keywords:  Adipose topography; barophenotype; obesity medicine; person centered obesity management

Year:  2021        PMID: 35136735      PMCID: PMC8793949          DOI: 10.4103/ijem.ijem_285_21

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


INTRODUCTION

Obesity, well-characterized as a disease entity, is diagnosed using body mass index (BMI). The same index is used as a stratification tool and as a target of intervention.[12] BMI, however, does not convey the entire complexity of obesity.[34] The presence or absence of comorbid conditions, which is added as a qualifying scheme, does not do full justice to the syndrome. Models such as Edmonton Obesity Scoring System (EOSS) and Severity of obesity, Expected prognosis, Comorbid conditions, Urgency of control, Risk of complications, Environmental factors, Dysfunction and disability (SECURED) promote a holistic approach to obesity care, whereas the BaroSixer model crafts pragmatic targets, balancing efficacy with safety.[56] These models, too, may not suffice as a descriptive and decision-making tool for all individuals seeking care for obesity. This situation is similar to that noted in diabetes, which is an equally heterogeneous condition.[7] The concept of glucophenotype and glycemic personality have been found useful in conveying the diabetes status, as well as informing management strategies in diabetes.[8]

THE BAROPHENOTYPE

We propose a similar concept, the barophenpotype, or barophenotypic personality, to diagnose and describe obesity, in a person-centered manner. The word “barophenotype” is a portmanteau of “baro,” which means weight, and phenotype, an accepted term in scientific literature. Barophenotype can be defined as the sum of all attributes, both biophysical and social, which contribute to the overall impact of obesity on health. Barophenotype includes the measurement of obesity (by using ethnicity-specific obesity indicators) and adds to its value by describing other obesity-related attributes.[19]

BAROPHENOTYPIC PERSONALITY

The term barophenotypic personality can also be used in place of barophenotype. Both terms have their advantages the latter is crisp and catchy, whereas the former carries a softer, more humane feeling with it.

The ABCDE of barophenotype

Irrespective of how we term it, barophenotype can be conveyed by an ABCDE rubric. The alliterative construct is learner-friendly and encourages the student's interest [Table 1].
Table 1

Barophenotype ABCDE

Adipose topography
 Severity of obesity
 Style/pattern of weight distribution
 The swiftness of weight change
 Syndromic features
Barometabolic behavior
 Diet
 Exercise/physical activity
 Addictions
 Stress and sleep
Comorbid status
 Metabolic
 Medical
 Mechanical
 Mood
Dysfunctionality
 Emotional
 Social
 Biomedical
 Biophysical
Enthusiasm and Expectations
 Weight loss expectation
 Willingness to change behavior
 Financial implications
 Social support
Barophenotype ABCDE A, or adipose topography, includes the severity and style of adiposity. BMI, waist circumference, and fat composition measure the severity of obesity, whereas the relative distribution of fat over various sites of the body provides an overview of its metabolic impact.[10] The swiftness with which obesity develops, reverses, or recurs, offers insights regarding the etiology of the disease, behavior of the patient, and appropriate therapeutic options. Adipose topography gives diagnostic clues to the etiology of various disorders like in Cushing's syndrome there is one particular pattern of fat distribution predominantly over the trunk, upper torso, and face. Similarly, certain endocrine conditions related to insulin resistance, like lipodystrophy syndrome, are fundamentally categorized on the basis of topographic barophenotype of the person.[11] Thus, this term “adipose topography” Helps in the selection of the molecule for the treatment of the particular disorder (e. g., pioglitazone). B, viz., barometabolic behavior, is a psychosocial assessment of the individual, encompassing her or his dietary patterns, meal composition, the quantity of food intake and nutrient adequacy; frequency, duration, intensity, and type of physical activity or exercise; and stress levels, sleep hygiene, and substance use/abuse.[5] C, in the ABCDE rubric, implies the status of comorbid conditions and complications. This includes metabolic and endocrine disease such as diabetes, polycystic ovarian syndrome (PCOS), dyslipidemia, and gout, nonalcoholic fatty liver diseases, medical illnesses such as heart failure, obstructive sleep apnea, and cholelithiasis, as well as mechanical or musculoskeletal challenges like osteoarthritis and specific endocrinal alterations other than diabetes attributed to the obesity like late-onset hypogonadism (LOH) and changes in thyroid dysfunction.[6] D, or dysfunctionality, represents the main challenges posed by obesity to quality of life. The emotional, social, or biophysical (such as limitation of exercise capacity, or in locomotion) challenges faced by the patient allow the obesity care provider to craft a meaningful plan of management for him or her.[12] The last letter of our acronym on barophenotype, E, is the strongest reason to term it as barophenotypic personality. The enthusiasm and expectations of the patient play an important role in determining ideation and initiation of therapy, adherence to suggested management protocols, and final outcomes. His or her expectations from a weight loss program, willingness to change behavior, and availability of social/financial support, all contribute to the overall barophenotype.[5]

Application of the ABCDE framework in clinical practice

The barophenotype is a framework that helps assess and define the impact of obesity on a particular individual. A barophenotypic approach allows the choice of appropriate treatment and monitoring strategies for person-centered obesity care [Table 2]. It also facilitates conversation regarding realistic goal-setting based upon the understanding of the rights and responsibilities of both patient and provider.
Table 2

Barophenotypic choice of therapy pragmatic pointers

DOMAINDIAGNOSISNON PHARMACOLOGICALPHARMACOLOGICALOTHERS
Adipose topography  severity  style  swiftness  syndromicConsider secondary causes for childhood-onset, sudden onset, atypically distributed obesity. (Lipodystrophy, Lipoedema, etc) Look for stigmata of syndromic obesityConsider behavior assessment and therapy for cyclic weight changeUse severity of obesity as a tool for risk stratification and initiation of therapy. Specific inherited conditions may respond to drugs like setmelanotide.Consider bariatric surgery for severe obesity, liposuction, or cosmetic surgery for atypical distribution
Barometabolic behavior  diet  exercise  addictions  stress and sleepUse barophenotype behavior to help diagnose etiology of exogenous obesity; psychogenic obesityPlan intensive behavioral therapy based on current behavior 0Use calorie restriction mimetics and exercise mimetics as requiredPostpone bariatric surgery until bar metabolic behavior is optimized
Comorbid status  metabolic  medical  mechanical  moodAssess target organ damage, comorbid features, and impact of obesityEnsure that diet/exercise prescriptions are appropriate for the 4M needs and limitationsEnsure metabolic and medical optimization while prescribing weight-lowering therapy. Keep contraindication of drugs in mindOffer medical orthopedic and psychiatric treatment as needed
Dysfunctionality  emotional  social  quality of life  financialExplore the limiting factor(s) to the achievement of optimal healthSuggest changes in lifestyle and rehabilitative measures can maximize functionalityKeep this in mind while crafting treatment strategiesOffer medical orthopedic and psychiatric treatment as needed
Enthusiasm and Expectations  the expectation of weight loss willingness to change financial strength availability of supportAssess sincerity and capability in starting treatment, and adhering to itSuggest diet and exercise options that are available, affordable, and acceptableSuggest medical treatment which is easy to adhere toEnsure adequate counseling; be pragmatic
Barophenotypic choice of therapy pragmatic pointers The barophenotype utility extends beyond individual clinical care. Analysis of the concept at a macro level can inform health care policy, in terms of provision of health care facilities, including behavioral, nutritional, medical, and surgical support.

CLINICAL IMPLICATIONS

This framework of the barophenotype will guide the clinician to intercept the patho- physiology at its root. Employing this stratification, a holistic strategy to treatment of a chronic disease like obesity can be chalked out as it addresses the obese person as a whole, including the flexibility and compliance to treatment. In addition, the comorbidities associated with obesity, which are the primary cause of morbidity and mortality are given due importance in this model thereby steering us away from a myopic approach towards the myriad complications.

CONCLUSION

The obesity pandemic is all-pervasive, affecting people regardless of gender, prosperity, or geography.[1314] As we face the pandemic of obesity, a holistic approach may be better than a piecemeal approach in dealing with this complex disease. It is important to describe a problem comprehensively, whereas a general approach focuses on obesity as a simple imbalance between energy intake and energy expenditure. This is a flawed concept, as this focuses on “how” obesity occurred. Obesity has a complex origin, from biology, behavior, society, and environment. Hence, we strongly encourage the use of the barophenotype-based characterization, which would instead focus on “why” obesity occurred and offer a multipronged solution for characterizing the disease as well as the person. The wide use of the barophenotype- based characterization would, we feel, fuel holistic thinking, learning, and management of obesity, and eventually help us better manage the millions of people affected by obesity and its complications. As we face the pandemic of obesity, a piecemeal approach in dealing with this complex disease may not yield rich dividends. Hence, we strongly encourage this multipronged approach in characterizing the disease as well as the person, in order to achieve treatment success.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  14 in total

1.  The gluco-phenotype.

Authors:  Sanjay Kalra; Yashdeep Gupta
Journal:  J Pak Med Assoc       Date:  2016-01       Impact factor: 0.781

2.  Ethnicity-specific cut-offs that predict co-morbidities: the way forward for optimal utility of obesity indicators.

Authors:  Nitin Kapoor; John Furler; Thomas V Paul; Nihal Thomas; Brian Oldenburg
Journal:  J Biosoc Sci       Date:  2019-04-04

3.  Person-centred Obesity Care - Techniques, Thresholds, Tools and Targets.

Authors:  Sanjay Kalra; Nitin Kapoor; Sunil Kota; Sambit Das
Journal:  Eur Endocrinol       Date:  2020-02-04

4.  The glycaemic personality: A SURE framework of person-centred choice in diabetes care.

Authors:  Sanjay Kalra; Hinde Iraqi; Rakesh Sahay; Saptarshi Bhattacharya
Journal:  J Pak Med Assoc       Date:  2020-07       Impact factor: 0.781

5.  The ultimate triumph of obesity.

Authors:  J Foreyt; K Goodrick
Journal:  Lancet       Date:  1995-07-15       Impact factor: 79.321

6.  Metabolic Score for Visceral Fat (METS-VF) Estimation - A Novel Cost-Effective Obesity Indicator for Visceral Adipose Tissue Estimation.

Authors:  Nitin Kapoor; Stephen A Jiwanmall; Munaf B Nandyal; Dheeraj Kattula; Sandhiya Paravathareddy; Thomas V Paul; John Furler; Brian Oldenburg; Nihal Thomas
Journal:  Diabetes Metab Syndr Obes       Date:  2020-09-16       Impact factor: 3.168

7.  The SECURE model: A comprehensive approach for obesity management.

Authors:  Nitin Kapoor; Sanjay Kalra; Sunil Kota; Sambit Das; Stephen Jiwanmall; Rakesh Sahay
Journal:  J Pak Med Assoc       Date:  2020-08       Impact factor: 0.781

Review 8.  The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.

Authors:  Rebecca J Brown; David Araujo-Vilar; Pik To Cheung; David Dunger; Abhimanyu Garg; Michelle Jack; Lucy Mungai; Elif A Oral; Nivedita Patni; Kristina I Rother; Julia von Schnurbein; Ekaterina Sorkina; Takara Stanley; Corinne Vigouroux; Martin Wabitsch; Rachel Williams; Tohru Yorifuji
Journal:  J Clin Endocrinol Metab       Date:  2016-10-06       Impact factor: 5.958

9.  Epidemiology of overweight and obesity in Indian adults - A secondary data analysis of the National Family Health Surveys.

Authors:  Madhur Verma; Milan Das; Priyanka Sharma; Nitin Kapoor; Sanjay Kalra
Journal:  Diabetes Metab Syndr       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.